|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Olux (Clobetasol Topical). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (4)
Cases resulting in a serious event (4)
Cases resulting in other serious reactions (4)
Adverse event in 3 year old male receiving Olux (Clobetasol Topical)
Reported by a individual with unspecified qualification from United States on 2007-07-18
Patient: 3 year old male
Adverse reactions / side effects: OFF Label USE, Vomiting, Accidental Drug Intake by Child
Suspect drug(s):
Olux (Clobetasol Topical)
Adverse event in 2 year old male receiving Olux (Clobetasol Topical)
Reported by a physician from United States on 2007-07-06
Patient: 2 year old male
Adverse reactions / side effects: Vomiting, Accidental Exposure
Suspect drug(s):
Olux (Clobetasol Topical)
Adverse event in 7 year old female receiving Olux (Clobetasol Topical)
Reported by a physician from United States on 2007-04-05
Patient: 7 year old female, weighing 21.8 kg (47.9 pounds)
Adverse reactions / side effects: Blood Cortisol Decreased, Growth Retardation
Suspect drug(s):
Luxiq
Dosage: 0.12 pct; ;top
Administration route: Topical
Indication: Alopecia Totalis
Start date: 2005-08-08
End date: 2006-08-01
Olux
Dosage: 0.05 pct;biw;top
Administration route: Topical
Indication: Alopecia Totalis
Start date: 2005-08-08
End date: 2006-08-01
Kenalog
Dosage: 15 mg;qm;
Indication: Alopecia Totalis
Adverse event in 7 year old female receiving Olux (Clobetasol Topical)
Reported by a physician from United States on 2007-01-25
Patient: 7 year old female, weighing 21.8 kg (47.9 pounds)
Adverse reactions / side effects: Blood Cortisol Decreased, Growth Retardation, Adrenal Neoplasm
Suspect drug(s):
Luxiq
Dosage: 0.12 pct; top
Administration route: Topical
Indication: Alopecia Totalis
Start date: 2005-08-08
End date: 2006-08-01
Olux
Dosage: 0.05 pct; biw; top
Administration route: Topical
Indication: Alopecia Totalis
Start date: 2005-08-08
End date: 2006-08-01
Kenalog
Dosage: 15 mg; qm;
Indication: Alopecia Totalis
|
